https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Recent advances in the preparation and applications of organo-functionalized porous materials https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:40466 2 capture and utilization, and drug delivery. The properties and the performance of these unique materials can be altered with suitable modifications on their surface. In this review, we summarize the recent advances in the preparation and applications of organo-functionalized porous materials with different structures. Initially, a brief historical overview of functionalized porous materials is presented, and the subsequent sections discuss the recent developments and applications of various functional porous materials. In particular, the focus is given on the various methods used for the preparation of organo-functionalized materials and their important roles in the heterogenization of homogeneous catalysts. A special emphasis is also given on the applications of these functionalized porous materials for catalysis, CO2 capture and drug delivery.]]> Wed 30 Aug 2023 14:39:22 AEST ]]> Physiological and pharmaceutical considerations for rectal drug formulations https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:45033 Wed 26 Oct 2022 10:59:52 AEDT ]]> Microneedles: a smart approach and increasing potential for transdermal drug delivery system https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:44995 Wed 26 Oct 2022 09:22:09 AEDT ]]> Advances in oral drug delivery for regional targeting in the gastrointestinal tract - influence of physiological, pathophysiological and pharmaceutical factors https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:38577 Wed 22 Mar 2023 17:23:53 AEDT ]]> Silica-based nanomaterials as drug delivery tools for skin cancer (melanoma) treatment https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:39596 Wed 15 Jun 2022 12:47:16 AEST ]]> Emerging era of "somes": polymersomes as versatile drug delivery carrier for cancer diagnostics and therapy https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:47180 Wed 14 Dec 2022 15:55:30 AEDT ]]> Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:47141 Wed 14 Dec 2022 15:27:43 AEDT ]]> Albumin-micelles via a one-pot technology platform for the delivery of drugs https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:19522 Wed 11 Apr 2018 13:22:24 AEST ]]> Female reproductive tract pain: targets, challenges, and outcomes https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:18783 Wed 11 Apr 2018 12:33:36 AEST ]]> Albendazole loaded albumin nanoparticles for ovarian cancer therapy https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:19520 Wed 11 Apr 2018 09:43:00 AEST ]]> Smart drug delivery system based on core-shell silica nanomaterials for prostate cancer https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51088 Wed 06 Mar 2024 15:14:42 AEDT ]]> Whether a novel drug delivery system can overcome the problem of biofilms in respiratory diseases? https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:31021 Wed 06 Apr 2022 13:59:15 AEST ]]> Advances and challenges of liposome assisted drug delivery https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:22593 Tue 26 Feb 2019 13:23:46 AEDT ]]> A Qualitative Exploration of Mental Health Services Provided in Community Pharmacies https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:50425 Tue 25 Jul 2023 18:48:29 AEST ]]> Increasing complexity and interactions of oxidative stress in chronic respiratory diseases: an emerging need for novel drug delivery systems https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:47625 Tue 24 Jan 2023 14:02:31 AEDT ]]> Advanced drug delivery systems can assist in targeting coronavirus disease (COVID-19): a hypothesis https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:49602 Tue 23 May 2023 15:26:55 AEST ]]> On strongly unimodal third-order SISO linear systems with applications to pharmacokinetics https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:42007 Tue 16 Aug 2022 16:51:17 AEST ]]> Patented therapeutic drug delivery strategies for targeting pulmonary diseases https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:46320 Tue 15 Nov 2022 15:56:23 AEDT ]]> Organic bioelectronics: materials and biocompatibility https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:34485 Tue 03 Sep 2019 17:55:15 AEST ]]> Advances in nanoparticulate drug delivery approaches for sublingual and buccal administration https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36623 Thu 28 Oct 2021 13:02:10 AEDT ]]> Immunological axis of curcumin-loaded vesicular drug delivery systems https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:33591 Thu 22 Nov 2018 13:41:26 AEDT ]]> Polyethylene glycol coated magnetic nanoparticles: hybrid nanofluid formulation, properties and drug delivery prospects https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:38568 2O4, CoFe2O4 and Fe3,O4) coated with PEG for MNF formulation and evaluated the loading/release efficacy of doxorubicin (DOX), an anticancer drug. We have presented in detail the drug loading capacity and the time-dependent cumulative drug release of DOX from PEG-coated MNPs based MNFs. Specifically, we have selected three different MNPs (NiFe2O4, CoFe2O4 and Fe3O4) coated with PEG for the MNFs and compared their variance in the loading/release efficacy of DOX, through experimental results fitting into mathematical models. DOX loading takes the order in the MNFs as CoFe2O4 > NiFe2O4 > Fe3O4. Various drug release models were suggested and evaluated for the individual MNP based NFs. While the non-Fickian diffusion (anomalous) model fits for DOX release from PEG coated CoFe2O4, PEG coated NiFe2O4 NF follows zero-order kinetics with a slow drug release rate of 1.33% of DOX per minute. On the other hand, PEG coated NiFe2O4 follows zero-order DOX release. Besides, several thermophysical properties and magnetic susceptibility of the MNFs of different concentrations have been studied by dispersing the MNPs (NiFe2O4, CoFe2O4 and Fe3O4) in the base fluid at 300 K under ultrasonication. This report on the DOX loading/release capability of MNF will set a new paradigm in view that MNF can resolve problems related to the self-heating of drug carriers during mild laser treatment with its thermal conducting properties.]]> Thu 04 Nov 2021 13:58:14 AEDT ]]> Multi-drug resistant Mycobacterium tuberculosis & oxidative stress complexity: emerging need for novel drug delivery approaches https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:33588 Mycobacterium tuberculosis, Mtb) treatment involves multiple drug regimens for a prolonged period. However, the therapeutic benefit is often limited by poor patient compliance, subsequently leading to treatment failure and development of antibiotic resistance. Notably, oxidative stress is a crucial underlying factor that adversely influences the various treatment regimens in tuberculosis. Little information is available with advanced drug delivery systems that could be effectively utilized, in particular, for targeting the oxidative stress in tuberculosis. Thus, this presents an opportunity to review the utility of various available, controlled-release drug delivery systems (e.g., microspheres, liposomes, niosomes, solid lipid nanoparticles, dendrimers) that could be beneficial in tuberculosis treatments. This will help the biological and formulation scientists to pave a new path in formulating a treatment regimen for multi-drug resistant Mtb.]]> Thu 03 Feb 2022 12:21:12 AEDT ]]> MicroRNAs as therapeutics for future drug delivery systems in treatment of lung diseases https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:31022 Thu 03 Feb 2022 12:19:12 AEDT ]]> Intracellular tracking of drug release from pH-sensitive polymeric nanoparticles via FRET for synergistic chemo-photodynamic therapy https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:41839 50 = 0.47 μg/mL) and better therapeutic efficacy than that of free EPI in vivo. Conclusions: This work provided a versatile strategy to fabricate nanoassemblies for intracellular tracking of drug release and synergistic chemo-photodynamic therapy.]]> Thu 01 Sep 2022 13:18:20 AEST ]]> Reversible pH-triggered encapsulation and release of pyrene by adsorbed block copolymer micelles https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:4447 Sat 24 Mar 2018 07:18:06 AEDT ]]> Triple Surfactant Assisted Synthesis of Novel Core-Shell Mesoporous Silica Nanoparticles with High Surface Area for Drug Delivery for Prostate Cancer https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48220 Sat 11 Mar 2023 12:36:58 AEDT ]]> Recent Advancement of Biopolymers and Their Potential Biomedical Applications https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:44749 Mon 24 Oct 2022 08:42:45 AEDT ]]> Preventing Preterm Birth: New Approaches to Labour Therapeutics using Nanoparticles https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:47510 Mon 23 Jan 2023 12:08:39 AEDT ]]> Silica-Based Nanoparticles as Drug Delivery Vehicles for Prostate Cancer Treatment https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:49526 Mon 22 May 2023 08:31:22 AEST ]]> Impact of gastric and bowel surgery on gastrointestinal drug delivery https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:50127 Mon 17 Jul 2023 11:12:15 AEST ]]> Cosolvent effects on the structure and thermoresponse of a polymer brush: PNIPAM in DMSO-water mixtures https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51170 Mon 13 Nov 2023 08:46:57 AEDT ]]> Electroporation of outer membrane vesicles derived from Pseudomonas aeruginosa with gold nanoparticles https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:37327 Mon 12 Oct 2020 12:49:23 AEDT ]]> The emergence of nanoporous materials in lung cancer therapy https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51383 Mon 04 Sep 2023 10:37:52 AEST ]]> Hydrogel based drug delivery systems: a review with special emphasis on challenges associated with decontamination of hydrogels and biomaterials https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:32346 Fri 25 May 2018 13:33:06 AEST ]]> Interactions between microbiome and lungs: paving new paths for microbiome based bio-engineered drug delivery systems in chronic respiratory diseases https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:37006 Fri 22 Apr 2022 10:21:09 AEST ]]> A Dual Protective Drug Delivery System Based on Lipid Coated Core-Shell Mesoporous Silica for Efficient Delivery of Cabazitaxel to Prostate Cancer Cells https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:53873 Fri 19 Jan 2024 12:38:43 AEDT ]]> Pulmonary Bioadhesive Drug Delivery Systems and Their Applications https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:45706 Fri 04 Nov 2022 08:55:56 AEDT ]]> Drug delivery to the human and mouse uterus using immunoliposomes targeted to the oxytocin receptor https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:32098 Fri 03 Dec 2021 10:35:09 AEDT ]]>